Telix Pharmaceuticals Limited (TLX)

11.61 AUD

0.12

1.02%

Last update Dec 18, 11:00 AM AEDT

Main market

Day range

11.61

11.3

11.72

Previous close

11.73000

Open

11.62

Access this stock data via API

Telix Pharmaceuticals Limited

11.61

0.12

1.02%

Revenue estimate	Next quarter (Dec 2025)	Current year (Dec 2025)	Next year (Dec 2026)
Number of Analysts	2	14	16
Avg. estimate	331.38M	1.24B	1.45B
Low estimate	326.92M	1.23B	1.30B
High estimate	335.84M	1.27B	1.69B
Last year sales	—	783.21M	1.24B
Sales growth	—	0.59	0.17

Access /revenue_estimate data via our API — starting from the Ultra plan.

EPS revisions	Current year (Dec 2025)	Next year (Dec 2026)
Up last 7 days	1	1
Up last 30 days	1	1
Down last 7 days	0	0
Down last 30 days	0	0

Access /eps_revisions data via our API — starting from the Ultra plan.

Buy

7.1%

Neutral

64.3%

Buy

28.6%

Strong buy

Access /recommendations data via our API — starting from the Ultra plan.

Firm	Date	Action
JP Morgan	Aug 28, 2025	Downgrade

Access /analyst_ratings/light data via our API — starting from the Ultra plan.

Telix Pharmaceuticals Limited